Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

RNA Molecule Is Behind Behavior Changes Cued by Environment

Published: Thursday, September 05, 2013
Last Updated: Thursday, September 05, 2013
Bookmark and Share
UCSF study may point to key mechanism of cellular memory.

Quick changes in behavior – in worms, at least – can be triggered by a unique form of the molecule RNA acting within the nucleus of a cell, UC San Francisco researchers have discovered.

The finding adds to mounting evidence for the importance of RNA in controlling gene activity, for its likely role in disease and for its potential as a therapeutic target.

Recognition of RNA’s importance has led the National Institutes of Health and other research organizations to fund more research directed toward better understanding the molecule’s role in disease and its therapeutic potential.

In a study published online on Aug. 29 in the journal Cell, scientists led by UCSF’s Noelle L’Etoile, PhD, found that the nerve cells of the tiny nematode worm C. elegans quickly learn to stop following a scent and eventually ignore it after an odor fails to lead the worm to food.

The researchers speculate that a similar biological mechanism involving RNA might drive long-lasting physiological changes in many types of human cells as they adapt to changes in the surrounding environment. “Our work indicates a mechanism by which environmentally relevant experiences may regulate gene expression, thereby shaping behavior in a specific and dynamic fashion,” said L’Etoile, an associate professor in the UCSF School of Dentistry's Department of Cell & Tissue Biology.

Therapeutic Possibilities with RNA Interference

The behavior change is a consequence of a negative feedback triggered inside a nerve cell, the researchers determined.

The particular form of RNA responsible for the rapid behavior change is called endogenous, small interfering RNA (endo siRNA), and until now, nobody had described a dynamic physiological role for it, let alone one that regulates behaviors, according to L’Etoile. So far, endo siRNA has been identified in yeast, worms and fruit flies, but not yet in mammals such as humans.

Endo siRNA is one a several types of short RNA molecules that researchers have discovered engage in “RNA interference.” Although it was not discovered until the late 1990s, nearly 40 years after the genetic code for making proteins from genes was identified, the phenomenon of RNA interference now is known to play an important role in fighting viral infection and in preventing genetic mayhem during reproduction by preventing parts of the genome known as “jumping genes” from moving and disrupting DNA within stable, vital genes.

Scientists’ growing understanding of the scope of RNA interference has inspired new experimental strategies for manipulating gene activity therapeutically.

Worm Nerve Cells are a Window on Basic Biology

Over the past two decades, UCSF researchers – including former UCSF faculty member Cori Bargmann, PhD, now at Rockefeller University – have used the worm as a model for exploring the underlying basis of behaviors.

Among other discoveries, Bargmann found four nerve cells that the worm uses to detect odors in the environment and to track down its favorite food: tasty bacteria. She also found hundreds of odor receptor proteins that the worm uses to detect specific scents.

A decade ago, as a post-doctoral fellow in Bargmann’s lab, L’Etoile cloned a gene for a protein called odr-1, needed for odor recognition.

In the newly published Cell study, the researchers probed how just one nerve cell in the worm responds to the scent of butanone, one of the chemicals that can signal the location of bacteria. Bargmann had earlier discovered that when worms are presented with butanone absent any bacteria, they adapt within an hour and stop gravitating toward the source of the chemical. “This change in behavior indicated a memory formation, and we wanted to know the molecular basis of this,” L’Etoile said.

Endo siRNA remains one of the least understood agents of RNA interference, according to L’Etoile.

It is made from a gene’s specific messenger RNA, the sequence of nucleic acid building blocks that carries the genetic blueprint of a protein to the cell’s protein-making machinery outside the nucleus. As a consequence, endo siRNA specifically targets only that gene, L’Etoile said, unlike other types of RNAs involved in RNA interference. Endo siRNA also acts a step earlier to block gene activity, by getting into the cell’s nucleus and stopping the formation of new messenger RNA, rather than simply by destroying existing messenger RNA in the cell’s cytoplasm.

Endo siRNA specific for the odr-1 gene stops the gene from making the messenger RNA, the researchers found in their new study. L’Etoile’s collaborator, Scott Kennedy, PhD, of the University of Wisconsin, Madison, determined how endo siRNA can ride on specific proteins to get into the nucleus where it can act to turn off genes. Bi-Tzen Juang, PhD, a postdoctoral fellow in L’Etoile’s lab, conducted experiments showing that a protein called EGL-4, acting downstream from odr-1, also is needed for the worm to adapt to the unrewarding butanone signal.

“This mechanism allows an environmental stimulus to potentially dial down the activity of any gene,” L’Etoile said. “Thus any gene may sow the seeds of its own inactivation under the right circumstances.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
Monday, November 23, 2015
Double Enzyme Hit May Explain Common Cancer Drug Side Effect
Mouse study suggests genomic screening before treatment may help prevent anemia.
Wednesday, October 14, 2015
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.
Tuesday, September 29, 2015
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Delivering Drugs to the Right Place
Thomas Weimbs has developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease.
Monday, June 29, 2015
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
Thursday, June 11, 2015
Genetic Markers for Detecting and Treating Ovarian Cancer
Custom bioinformatics algorithm identifies human mRNAs that distinguish ovarian cancer cells from normal cells and provide new therapeutic targets
Wednesday, May 27, 2015
Using microRNA Fit to a T (Cell)
Researchers show B cells can deliver potentially therapeutic bits of modified RNA.
Friday, November 29, 2013
Digging Deeper Into Cancer
What a pathologist looks for in a Pap test sample, but hopes not to find, are oddly shaped cells with abnormally large nuclei. The same is true for prostate and lung cancer biopsies.
Tuesday, November 19, 2013
Nanotech Method Show Promise Against Pancreatic Cancer
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer.
Monday, November 18, 2013
Researchers Un-Junking Junk DNA
A study shines a new light on molecular tools our cells use to govern regulated gene expression.
Wednesday, November 13, 2013
Powerful Anti-Cancer Compound Safely Delivered
Researchers have discovered a way to effectively deliver staurosporine (STS).
Tuesday, October 22, 2013
Pan-Cancer Studies Find Common Patterns Shared by Different Tumor Types
Findings may open up new treatment options by extending therapies effective in one cancer type to others with a similar genomic profile.
Wednesday, October 02, 2013
Disabling Enzyme Cripples Tumors, Cancer Cells
Knocking out a single enzyme dramatically cripples the ability of aggressive cancer cells to spread and grow tumors.
Thursday, September 05, 2013
Scientists Devise Innovative Method to Profile and Predict the Behavior of Proteins
A class of proteins that are made up of multiple, interlocking molecular components, enzymes perform a variety of tasks inside each cell.
Friday, August 09, 2013
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos